Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit

BACKGROUND: Botulinum toxin A (BoNT‐A) is an effective treatment for cervical dystonia. Nevertheless, up to 30% to 40% patients discontinue treatment, often because of poor response. The British Neurotoxin Network (BNN) recently published guidelines on the management of poor response to BoNT‐A in ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mov Disord Clin Pract
Main Authors: Tucker, Harry, Osei‐Poku, Foster, Ashton, Diane, Lally, Rachael, Jesuthasan, Aaron, Latorre, Anna, Bhatia, Kailash P., Alty, Jane E., Kobylecki, Christopher
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088097/
https://ncbi.nlm.nih.gov/pubmed/33977116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.13181
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados